Amyotrophic lateral sclerosis & frontotemporal degeneration

Keyphrases

Publications

volume 25, number 3-4, 2024

Frederik Hobin, Joke De Vocht, Nikita Lamaire, Hilde Beyens, Fouke Ombelet, Philip Van Damme
Specialized multidisciplinary care improves ALS survival in Belgium: a population-based retrospective study. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Mark R Janse van Mantgem, Maaike L Soors D'Ancona, Myrte Meyjes, Leonard H Van Den Berg, Elles Steenhagen, Annemieke Kok, Ruben P A van Eijk
A comparison between bioelectrical impedance analysis and air-displacement plethysmography in assessing fat-free mass in patients with motor neurone diseases: a cross-sectional study. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Ryo Otani, Kazumoto Shibuya, Toshio Shimizu, Takamasa Kitaoji, Yu-Ichi Noto, Kota Bokuda, Hideki Kimura, Tomoki Suichi, Keigo Nakamura, Hiroki Kano, Marie Morooka, Yuya Aotsuka, Moeko Ogushi, Sonoko Misawa, Satoshi Kuwabara
Diagnostic utility of Gold Coast criteria for amyotrophic lateral sclerosis in Asia. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Elisabeth Kasper, Anna G M Temp, Verena Köckritz, Lisa Meier, Judith Machts, Stefan Vielhaber, Andreas Hermann, Johannes Prudlo
Verbal expressive language minimally affected in non-demented people living with amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Jade Howard, Hilary L Bekker, Christopher J McDermott, Alisdair Mcneill
A report of resources used by clinicians in the UK to support motor neuron disease genomic testing. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Tatsuto Hamatani, Naoki Atsuta, Fumiya Sano, Ryoichi Nakamura, Yukikazu Hayashi, Gen Sobue
ALSFRS-R decline rate prior to baseline is not useful for stratifying subsequent progression of functional decline. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Sean White, Alicia O'Cathain, Vanessa Halliday, Michael Bradburn, Christopher J McDermott
Supporting people with Motor Neuron Disease (MND) to make decisions about gastrostomy feeding tube placement: a survey of UK healthcare professionals' practice and beliefs. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Carolyn Anne Young, Amina Chaouch, Christopher J McDermott, Ammar Al-Chalabi, Suresh K Chhetri, Kevin Talbot, Andrea Malaspina, Roger Mills, Alan Tennant
Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Jade Howard, Hilary L Bekker, Christopher J McDermott, Alisdair Mcneill
A report of resources used by clinicians in the UK to support motor neuron disease genomic testing. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Sean White, Alicia O'Cathain, Vanessa Halliday, Michael Bradburn, Christopher J McDermott
Supporting people with Motor Neuron Disease (MND) to make decisions about gastrostomy feeding tube placement: a survey of UK healthcare professionals' practice and beliefs. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Ran S Rotem, Andrea Bellavia, Sabrina Paganoni, Marc G Weisskopf
Medication use and risk of amyotrophic lateral sclerosis: using machine learning for an exposome-wide screen of a large clinical database. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Frederik Hobin, Joke De Vocht, Nikita Lamaire, Hilde Beyens, Fouke Ombelet, Philip Van Damme
Specialized multidisciplinary care improves ALS survival in Belgium: a population-based retrospective study. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Ryo Otani, Kazumoto Shibuya, Toshio Shimizu, Takamasa Kitaoji, Yu-Ichi Noto, Kota Bokuda, Hideki Kimura, Tomoki Suichi, Keigo Nakamura, Hiroki Kano, Marie Morooka, Yuya Aotsuka, Moeko Ogushi, Sonoko Misawa, Satoshi Kuwabara
Diagnostic utility of Gold Coast criteria for amyotrophic lateral sclerosis in Asia. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)
Carolyn Anne Young, Amina Chaouch, Christopher J McDermott, Ammar Al-Chalabi, Suresh K Chhetri, Kevin Talbot, Andrea Malaspina, Roger Mills, Alan Tennant
Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (3-4) (2024)

volume 25, number 5-6, 2024

Carolyn Anne Young, Amina Chaouch, Christopher J McDermott, Ammar Al-Chalabi, Suresh K Chhetri, Kevin Talbot, Timothy Harrower, Richard W Orrell, Joe Annadale, C Oliver Hanemann, Antonio Scalfari, Alan Tennant, Roger Mills, null null
Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Emma Rhodes, Sebleh Alfa, Hannah A Jin, Lauren Massimo, Lauren Elman, Defne Amado, Michael Baer, Colin Quinn, Corey T McMillan
Cognitive reserve in ALS: the role of occupational skills and requirements. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Eneida Mioshi, K Grant, E Flanagan, S Heal, H Copsey, R L Gould, M Hammond, L Shepstone, P A Ashford
An online intervention for carers to manage behavioral symptoms in motor neuron disease (MiNDToolkit): a randomized parallel multi-center feasibility trial. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Stephen A Goutman, Jonathan Boss, Dae Gyu Jang, Caroline Piecuch, Hasan Farid, Madeleine Batra, Bhramar Mukherjee, Eva L Feldman, Stuart A Batterman
Residential exposure associations with ALS risk, survival, and phenotype: a Michigan-based case-control study. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Eneida Mioshi, K Grant, E Flanagan, S Heal, H Copsey, R L Gould, M Hammond, L Shepstone, P A Ashford
An online intervention for carers to manage behavioral symptoms in motor neuron disease (MiNDToolkit): a randomized parallel multi-center feasibility trial. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Federico Maria Sopranzi, Andrea Faragalli, Marco Pompili, Flavia Carle, Rosaria Gesuita, Maria Gabriella Ceravolo
Incidence of amyotrophic lateral sclerosis before and during the COVID-19 pandemic: evidence from an 8-year population-based study in Central Italy based on healthcare utilization databases. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Lyndsay Didcote, Silia Vitoratou, Ammar Al Chalabi, Laura H Goldstein
What is the extent of reliability and validity evidence for screening tools for cognitive and behavioral change in people with ALS? A systematic review. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Eneida Mioshi, K Grant, E Flanagan, S Heal, H Copsey, R L Gould, M Hammond, L Shepstone, P A Ashford
An online intervention for carers to manage behavioral symptoms in motor neuron disease (MiNDToolkit): a randomized parallel multi-center feasibility trial. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Giuseppe Borghero, Vincenzo Pierri, Francesca Pili, Antonella Muroni, Tommaso Ercoli, Maria Ida Pateri, Silvy Pilotto, Alessandra Maccabeo, Adriano Chiò, Giovanni Defazio
Percutaneous gastrostomy, mechanical ventilation and survival in amyotrophic lateral sclerosis: an observational study in an incident cohort. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
T Katangwe-Chigamba, E Flanagan, Eneida Mioshi
Implementation of the MiNDToolkit intervention for the management of behavioral symptoms in MND by healthcare professionals: a mixed-methods process evaluation. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
T Katangwe-Chigamba, E Flanagan, Eneida Mioshi
Implementation of the MiNDToolkit intervention for the management of behavioral symptoms in MND by healthcare professionals: a mixed-methods process evaluation. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Xinyi Zhang, Ye Sun, Xinzhe Zhang, Dongchao Shen, Shi Shu, Xunzhe Yang, Mingsheng Liu, Liying Cui, Qing Liu, Xue Zhang
Genotype-phenotype association and functional analysis of hnRNPA1 mutations in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
T Katangwe-Chigamba, E Flanagan, Eneida Mioshi
Implementation of the MiNDToolkit intervention for the management of behavioral symptoms in MND by healthcare professionals: a mixed-methods process evaluation. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
M Kelley Erb, Narghes Calcagno, Roland Brown, Katherine M Burke, Zoe A Scheier, Amrita S Iyer, Alison Clark, Max P Higgins, Mackenzie Keegan, Anoopum S Gupta, Stephen A Johnson, Sheena Chew, James D Berry
Longitudinal comparison of the self-administered ALSFRS-RSE and ALSFRS-R as functional outcome measures in ALS. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Saileyee Roychowdhury, Deepika Joshi, Vinay Kumar Singh, Mohammed Faruq, Parimal Das
Genetic and in silico analysis of Indian sporadic young onset patient with amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Qirui Jiang, Qianqian Wei, Lingyu Zhang, Tianmi Yang, Junyu Lin, Yi Xiao, Chunyu Li, Yanbing Hou, Ruwei Ou, Kuncheng Liu, Bi Zhao, Ying Wu, Xiaohui Lai, Hui Fang Shang
Peripheral immunity relate to disease progression and prognosis in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Emma Rhodes, Sebleh Alfa, Hannah A Jin, Lauren Massimo, Lauren Elman, Defne Amado, Michael Baer, Colin Quinn, Corey T McMillan
Cognitive reserve in ALS: the role of occupational skills and requirements. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Carolyn Anne Young, Amina Chaouch, Christopher J McDermott, Ammar Al-Chalabi, Suresh K Chhetri, Kevin Talbot, Timothy Harrower, Richard W Orrell, Joe Annadale, C Oliver Hanemann, Antonio Scalfari, Alan Tennant, Roger Mills, null null
Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Seward B Rutkove, Courtney E McIlduff, Elijah Stommel, Sean Levy, Christy Smith, Hilda Gutierrez, Sarah Verga, Soleil Samaan, Chebet Yator, Ajitesh Nanda, Lisa Pastel, Allaire Doussan, Kathy Phipps, Ethan Murphy, Ryan Halter
Assessing pulmonary function in ALS using electrical impedance tomography. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Stephen A Goutman, Jonathan Boss, Dae Gyu Jang, Caroline Piecuch, Hasan Farid, Madeleine Batra, Bhramar Mukherjee, Eva L Feldman, Stuart A Batterman
Residential exposure associations with ALS risk, survival, and phenotype: a Michigan-based case-control study. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Seward B Rutkove, Courtney E McIlduff, Elijah Stommel, Sean Levy, Christy Smith, Hilda Gutierrez, Sarah Verga, Soleil Samaan, Chebet Yator, Ajitesh Nanda, Lisa Pastel, Allaire Doussan, Kathy Phipps, Ethan Murphy, Ryan Halter
Assessing pulmonary function in ALS using electrical impedance tomography. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Robert J Nona, Robert D Henderson, Pamela A McCombe
Neutrophil-to-lymphocyte ratio at diagnosis as a biomarker for survival of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Emma Rhodes, Sebleh Alfa, Hannah A Jin, Lauren Massimo, Lauren Elman, Defne Amado, Michael Baer, Colin Quinn, Corey T McMillan
Cognitive reserve in ALS: the role of occupational skills and requirements. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Lyndsay Didcote, Ammar Al Chalabi, Laura H Goldstein
How the coronavirus pandemic affected the lives of people with ALS and their spouses in the UK from spouses' perspectives: a qualitative study. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Lyndal Henden, Liam G Fearnley, Dean Southwood, Andrew Smith, Dominic B Rowe, Matthew C Kiernan, Roger Pamphlett, Melanie Bahlo, Ian P Blair, Kelly Louise Williams
Short tandem repeat expansions in LRP12 are absent in cohorts of familial and sporadic amyotrophic lateral sclerosis patients of European ancestry. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Stephen A Goutman, Jonathan Boss, Dae Gyu Jang, Caroline Piecuch, Hasan Farid, Madeleine Batra, Bhramar Mukherjee, Eva L Feldman, Stuart A Batterman
Residential exposure associations with ALS risk, survival, and phenotype: a Michigan-based case-control study. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Laurel Officer, Carmel Armon, Paul Barkhaus, Morgan Beauchamp, Michael Benatar, Tulio Bertorini, Robert Bowser, Mark Bromberg, Andrew Brown, Olimpia Mihaela Carbunar, Gregory T Carter, Jesse Crayle, Keelie Denson, Eva Feldman, Timothy Fullam, Terry Heiman-Patterson, Carlayne Jackson, Sartaj Jhooty, Danelle Levinson, Xiaoyan Li, Alexandra Linares, Elise Mallon, Javier Mascias Cadavid, Christopher J McDermott, Tasnim Mushannen, Lyle Ostrow, Ronak Patel, Gary Pattee, Dylan Ratner, Yuyao Sun, John Sladky, Paul Wicks, Richard Bedlack
ALSUntangled #75: Portable neuromodulation stimulator therapy. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Danielle Boyce, Jaime Raymond, Theodore C Larson, Eddie Kirkland, D Kevin Horton, Paul Mehta
What do you think caused your ALS? An analysis of the CDC national amyotrophic lateral sclerosis patient registry qualitative risk factor data using artificial intelligence and qualitative methodology. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Tungki Pratama Umar, Nityanand Jain, Manthia Papageorgakopoulou, Rahma Sameh Shaheen, Jehad Feras AlSamhori, Muhammad Muzzamil, Andrejs Kostiks
Artificial intelligence for screening and diagnosis of amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Alexander A Hart, Andrea Swenson, Nandakumar S Narayanan, Jacob E Simmering
Rurality modifies the association between symptoms and the diagnosis of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Patricia Lillo, Pedro Zitko, Gladys Godoy-Reyes, Gabriela Asenjo, David Sáez, Gonzalo Cea, Pamela Navarrete, Daniel Valenzuela, Ricardo Hughes, Mark Heverin, Giancarlo Logroscino, Orla Hardiman
Incidence of amyotrophic lateral sclerosis in Chile. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Shelagh K Genuis, Westerly Luth, Claire Magnussen, Christine Vande Velde, David Taylor, null null, Wendy S Johnston
Patient engagement in research: lessons learned from CAPTURE ALS, a longitudinal observational ALS study. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Carolyn Anne Young, Amina Chaouch, Christopher J McDermott, Ammar Al-Chalabi, Suresh K Chhetri, Kevin Talbot, Timothy Harrower, Richard W Orrell, Joe Annadale, C Oliver Hanemann, Antonio Scalfari, Alan Tennant, Roger Mills, null null
Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Victoria K Shephard, Mikayla L Brown, Bryony A Thompson, Alisha Harpur, Luke McAlary
Rapid classification of a novel ALS-causing I149S variant in superoxide dismutase-1. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Danielle Boyce, Jaime Raymond, Theodore C Larson, Eddie Kirkland, D Kevin Horton, Paul Mehta
What do you think caused your ALS? An analysis of the CDC national amyotrophic lateral sclerosis patient registry qualitative risk factor data using artificial intelligence and qualitative methodology. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)
Evelyn O Talbott, Angela M Malek, Vincent C Arena, Fan Wu, Kristen Steffes, Ravi K Sharma, Jeanine Buchanich, Judith R Rager, Todd M Bear, Caroline A Hoffman, David Lacomis, Chris Donnelly, Jocelyn Mauna, John E Vena
Case-control study of environmental toxins and risk of amyotrophic lateral sclerosis involving the national ALS registry. Amyotrophic lateral sclerosis & frontotemporal degeneration 25 (5-6) (2024)